Ashford Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Ashford Capital Management's BMY Position: Q4 2020 in Review
Ashford Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 3,950 shares — an estimated $238K sold.
Ashford Capital Management first reported a position in BMY in Q2 2013 and held it in 25 quarters. The position peaked at $692K in Q4 2014. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.
- Ashford Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
- Ashford Capital Management sold 3,950 Bristol-Myers Squibb shares in Q4 2020, an estimated $238K.
- Ashford Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 25 quarters.
- Ashford Capital Management's Bristol-Myers Squibb position peaked at $692K in Q4 2014.
- 2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.
Based on Ashford Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.